Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer

Molecular Pharmaceutics

Volumn 9, Issue 8, 2012, Pages 2350-2357

  Chitkara, Deepak ^a,b   Singh, Saurabh ^a   Kumar, Virender ^a   Danquah, Michael ^a   Behrman, Stephen W ^a   Kumar, Neeraj ^b   Mahato, Ram I ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

combination; cyclopamine; drug delivery; gefitinib; micelles; pancreatic cancer

Indexed keywords

CASPASE 3; CASPASE 7; COPOLYMER; CYCLOPAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; METHOXY POLYETHYLENEGLYCOL B POLY (CARBONATE CO LACTIC ACID) COPOLYMER; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LINE L3.6PL; CELL LINE MIA PACA 2; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG POTENTIATION; DRUG RETENTION; GENE EXPRESSION; MICELLE; MOUSE; NONHUMAN; PANCREAS CANCER; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MALE; MICE; MICE, NUDE; MICELLES; PANCREATIC NEOPLASMS; QUINAZOLINES; VERATRUM ALKALOIDS;

EID: 84864701350     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3002792     Document Type: Article

References (32)

1. Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer Statistics, 2011 CA Cancer J. Clin. 2011, 61, 212-236
2. Li, D.; Xie, K.; Wolff, R.; Abbruzzese, J. L. Pancreatic cancer Lancet 2004, 363, 1049-1057 (Pubitemid 38410779)
3. Warshaw, A. L.; Fernandez-del Castillo, C. Pancreatic carcinoma N. Engl. J. Med. 1992, 326, 455-465
4. Berman, D. M.; Karhadkar, S. S.; Maitra, A.; Oca, R. M. d.; Gerstenblith, M. R.; Briggs, K.; Parker, A. R.; Shimada, Y.; Eshleman, J. R.; Watkins, D. N.; Beachy, P. A. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours Nature 2003, 425, 846-851 (Pubitemid 37351469)
5. Thayer, S. P.; Magliano, M. P. d.; Heiser, P. W.; Nielsen, C. M.; Roberts, D. J.; Lauwers, G. Y.; Qi, Y. P.; Gysin, S.; Castillo, C. F. n.-d.; Yajnik, V.; Antoniu, B.; McMahon, M.; Warshaw, A. L.; Hebrok, M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis Nature 2003, 425, 851-856 (Pubitemid 37355945)
6. Wang, Z.; Sengupta, R.; Banerjee, S.; Y., L.; Zhang, Y.; Rahman, K. M. W. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer Cancer Res. 2006, 66, 7653-7660 (Pubitemid 44289223)
7. Magliano, M. P. d.; Hebrok, M. Hedgehog signalling in cancer formation and maintenance Nature Rev. 2003, 3, 903-911 (Pubitemid 37500175)
8. Rubin, L. L.; Sauvage, F. J. d. Targeting the Hedgehog pathway in cancer Nature Rev. Drug Discovery 2006, 5, 1026-1033 (Pubitemid 44835129)
9. Krasinskas, A. M. EGFR Signaling in Colorectal Carcinoma Pathol. Res. Int. 2011, 2011, 1-6
10. Mangelberger, D.; Kern, D.; Loipetzberger, A.; Eberl, M.; Aberger, F. Cooperative Hedgehog-EGFR signaling Front. Biosci. 2012, 17, 90-99
11. Palma, V.; Altaba, A. R. i. Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex Development 2004, 131, 337-345 (Pubitemid 38181373)
12. Palma, V.; Lim, D. A.; Dahmane, N.; Sanchez, P.; Brionne, T. C.; Herzberg, C. D.; Gitton, Y.; Carleton, A.; Alvarez-Buylla, A.; Altaba, A. R. i. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain Development 2005, 132, 335-344 (Pubitemid 40268283)
13. Bigelow, R. L.; Jen, E. Y.; Delehedde, M.; Chari, N. S.; McDonnell, T. J. Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes J. Invest. Dermatol. 2005, 124, 457-465 (Pubitemid 40175896)
14. Mimeault, M.; Moore, E.; Moniaux, N. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells Int. J. Cancer 2006, 118, 1022-1031 (Pubitemid 43157681)
15. Mimeault, M.; Johansson, S. L.; Henichart, J.-P.; Depreux, P.; Batra, S. K. Cytotoxic Effects Induced by Docetaxel, Gefitinib, and Cyclopamine on Side Population and Nonside Population Cell Fractions from Human Invasive Prostate Cancer Cells Mol. Cancer Ther. 2010, 9, 617-630
16. Mimeault, M.; Johansson, S. L.; Vankatraman, G.; Moore, E.; Henichart, J.-P.; Depreux, P.; Lin, M.-F.; Batra, S. K. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells Mol. Cancer Ther. 2007, 6, 967-978 (Pubitemid 46554566)
17. Hu, W.; Liu, T.; Xiong, J.; Wang, C. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells Acta Pharmacol. Sin. 2007, 28, 1224-1230 (Pubitemid 47197786)
18. Wilson, S. R.; Strand, M. F.; Krapp, A.; Rise, F.; Petersen, D.; Krauss, S. Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified J. Pharm. Biomed. Anal. 2010, 52, 707-713
19. Danquah, M.; Fujiwara, T.; Mahato, R. I. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery Biomaterials 2010, 31, 2358-2370
20. Danquah, M.; Li, F.; Duke, C. B., III; Miller, D. D.; Mahato, R. I. Micellar Delivery of Bicalutamide and Embelin for Treating Prostate Cancer Pharm. Res. 2009, 26, 2081-2092
21. Steel, G. G.; Peckham, M. J. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity Int. J. Radiat. Oncol. Biol. Phys. 1979, 5, 85-91 (Pubitemid 9120186)
22. Feldmann, G.; Dhara, S.; Fendrich, V.; Bedja, D.; Beaty, R.; Mullendore, M.; Karikari, C.; Alvarez, H.; Iacobuzio-Donahue, C.; Jimeno, A.; Gabrielson, K. L.; Matsui, W.; Maitra, A. Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers Cancer Res. 2007, 67, 2187-2196 (Pubitemid 46424238)
23. Feldmann, G.; Habbe, N.; Dhara, S.; Bisht, S.; Alvarez, H.; Fendrich, V.; Beaty, R.; Mullendore, M.; Karikari, C.; Bardeesy, N.; Ouellette, M. M.; Yu, W.; Maitra, A. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer Gut 2008, 57, 1420-1430
24. Li, F.; Danquah, M.; Mahato, R. I. Synthesis and Characterization of Amphiphilic Lipopolymers for Micellar Drug Delivery Biomacromolecules 2010, 11, 2610-2620
25. Li, F.; Lu, Y.; Li, W.; Miller, D. D.; Mahato, R. I. Synthesis, formulation and in vitro evaluation of a novel microtubule destabilizer, SMART-100 J. Controlled Release 2010, 143, 151-158
26. Allen, C.; Maysinger, D.; Eisenberg, A. Nano-engineering block copolymer aggregates for drug delivery Colloids Surf., B 1999, 16, 3-27
27. Chenna, V.; Hu, C.; Pramanik, D.; Aftab, B. T.; Karikari, C.; Campbell, N. R.; Hong, S. M.; Zhao, M.; Rudek, M. A.; Khan, S. R.; Rudin, C. M.; Maitra, A. A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists Mol. Cancer Ther. 2012, 11, 165-173
28. Shintani, S.; Li, C.; Mihara, M.; Nakashiro, K.-i.; Hamakawa, H. Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells Cancer Lett. 2003, 201, 149-155 (Pubitemid 37357164)
29. Varnat, F.; Duquet, A.; Malerba, M.; Zbinden, M.; Mas, C.; Gervaz, P.; Ruiz i Altaba, A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion EMBO Mol. Med. 2009, 1 (6-7) 338-351
30. Wang, S.; Guo, P.; Wang, X.; Zhou, Q.; Gallo, J. M. Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models Mol. Cancer Ther. 2008, 7 (2) 407-417 (Pubitemid 351302534)
31. Lee, J.; Wu, X.; Magliano, M. P. d.; Peters, E. C.; Wang, Y.; Hong, J.; Hebrok, M.; Ding, S.; Cho, C. Y.; Schultz, P. G. A Small-Molecule Antagonist of the Hedgehog Signaling Pathway ChemBioChem 2007, 8, 1916-1919
32. Schiff, B. A.; McMurphy, A. B.; Jasser, S. A.; Younes, M. N.; Doan, D.; Yigitbasi, O. G.; Kim, S.; Zhou, G.; Mandal, M.; Bekele, B. N.; Holsinger, F. C.; Sherman, S. I.; Yeung, S.-C.; El-Naggar, A. K.; Myers, J. N. Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer Clin. Cancer Res. 2004, 10, 8594-8602 (Pubitemid 40053427)